Rafferty Asset Management’s Sana Biotechnology SANA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.02M	Buy	353,582 +79,420	+29%	+$313K	﹤0.01%	767
2025 Q4	$1.12M	Buy	274,162 +6,177	+2%	+$27.7K	﹤0.01%	778
2025 Q3	$951K	Buy	+267,985	New	+$969K	﹤0.01%	802
2025 Q2	–	Sell	-195,135	Closed	-$328K	–	1101
2025 Q1	$328K	Sell	195,135 -118,716	-38%	-$332K	﹤0.01%	938
2024 Q4	$512K	Sell	313,851 -10,680	-3%	-$31.8K	﹤0.01%	907
2024 Q3	$1.35M	Sell	324,531 -15,899	-5%	-$83.5K	﹤0.01%	729
2024 Q2	$1.86M	Sell	340,430 -155,502	-31%	-$1.24M	0.01%	667
2024 Q1	$4.96M	Buy	495,932 +58,318	+13%	+$437K	0.02%	477
2023 Q4	$1.79M	Buy	437,614 +112,732	+35%	+$415K	0.01%	699
2023 Q3	$1.26M	Sell	324,882 -10,901	-3%	-$58.6K	0.01%	731
2023 Q2	$2M	Sell	335,783 -72,462	-18%	-$418K	0.01%	643
2023 Q1	$1.33M	Sell	408,245 -103,480	-20%	-$413K	0.01%	723
2022 Q4	$2.02M	Buy	511,725 +82,559	+19%	+$404K	0.02%	574
2022 Q3	$2.58M	Buy	429,166 +58,859	+16%	+$425K	0.03%	455
2022 Q2	$2.38M	Sell	370,307 -114,625	-24%	-$730K	0.02%	429
2022 Q1	$4.01M	Buy	484,932 +287,779	+146%	+$2.33M	0.02%	430
2021 Q4	$3.05M	Buy	197,153 +124,729	+172%	+$2.4M	0.02%	535
2021 Q3	$1.63M	Sell	72,424 -14,876	-17%	-$312K	0.01%	688
2021 Q2	$1.72M	Buy	+87,300	New	+$1.98M	0.01%	732